MAPT and ovarian carcinoma: In addition to the correlation between MAPT and β-tubulin III levels and paclitaxel resistance in gastric cancer [23], downregulation of MAPT was also shown to improve taxane response in breast cancer cell lines [24] and in ovarian cancer three-dimensional collagen I matrix culture [22].